Yomogi® Saccharomyces cerevisiae HANSEN CBS 5926 (Synonym: Saccharomyces boulardii) also known as CNCM I-745
Natural Therapy Imports is an Australian company responsible for the supply and distribution of Yomogi® in Australia and New Zealand.
Yomogi® – Saccharomyces cerevisiae (boulardii) HANSEN CBS 5926 / CNCM I-745 is available in 20 & 50 capsule packs from selected pharmacies and medical/naturopathic dispensaries.
20 Capsule Packs RRP $15.00 50 Capsule Packs RRP $29.00
Yomogi® is a probiotic that comprises as its active substance 250 mg of lyophilized yeast cells that at batch release contains a minimum of 2.5 billion CFU (colony forming units) of a viable non-pathogenic cells of the yeast strain Saccharomyces cerevisiae (boulardii) HANSEN CBS 5926 / CNCM I-745. Saccharomyces boulardii is indicated for the treatment of diarrhoea, often a symptom of gastrointestinal disorders. Saccharomyces boulardii is able to help and support a healthy microbial environment.
Most medications containing lactose monohydrate do not have enough lactose present to affect people who are lactose intolerant, namely, those whose digestive systems do not possess the enzymes needed to digest lactose. However lactose-intolerant patients should ask their Doctor or healthcare practitioner whether or not they may safely take certain medications containing lactose.
Yomogi® does not require refrigeration. Yomogi® is lyophilized, a process of freeze drying that ensures the product is heat stable and maintains viable active cells, or colony forming units (CFU).